238 related articles for article (PubMed ID: 25160933)
21. No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy.
Calza L; Colangeli V; Magistrelli E; Manfredi R; Bon I; Re MC; Viale P
HIV Med; 2016 Sep; 17(8):631-3. PubMed ID: 27028348
[TBL] [Abstract][Full Text] [Related]
22. Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients.
Spagnuolo V; Galli L; Poli A; Salpietro S; Gianotti N; Piatti P; Cossarini F; Vinci C; Carini E; Lazzarin A; Castagna A
BMC Infect Dis; 2017 Jan; 17(1):43. PubMed ID: 28061820
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
Dauby N; De Wit S; Delforge M; Necsoi VC; Clumeck N
J Int AIDS Soc; 2011 Mar; 14():16. PubMed ID: 21443771
[TBL] [Abstract][Full Text] [Related]
24. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
Silverberg MJ; Abrams DI
Curr Opin HIV AIDS; 2009 Jan; 4(1):42-51. PubMed ID: 19339938
[TBL] [Abstract][Full Text] [Related]
25. AIDS-associated cancers: an emerging challenge.
Phatak UA; Joshi R; Badakh DK; Gosavi VS; Phatak JU; Jagdale RV
J Assoc Physicians India; 2010 Mar; 58():159-62. PubMed ID: 20848813
[TBL] [Abstract][Full Text] [Related]
26. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
27. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Costagliola D; Grabar S;
Clin Infect Dis; 2013 Dec; 57(11):1638-47. PubMed ID: 23899679
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
29. Malignancies in human immunodeficiency virus infected patients in India: Initial experience in the HAART era.
Sharma SK; Soneja M; Ranjan S
Indian J Med Res; 2015 Nov; 142(5):563-7. PubMed ID: 26658591
[TBL] [Abstract][Full Text] [Related]
30. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
31. Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.
Overton ET; Kitch D; Benson CA; Hunt PW; Stein JH; Smurzynski M; Ribaudo HJ; Tebas P
Clin Infect Dis; 2013 May; 56(10):1471-9. PubMed ID: 23386631
[TBL] [Abstract][Full Text] [Related]
32. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
34. [HIV-related malignancies: state of art].
Gobert A; Mounier N; Lavole A; Poizot-Martin I; Spano JP
Bull Cancer; 2014 Nov; 101(11):1020-9. PubMed ID: 25418594
[TBL] [Abstract][Full Text] [Related]
35. Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008.
Alvaro-Meca A; Micheloud D; Jensen J; Díaz A; García-Alvarez M; Resino S
Pediatr Infect Dis J; 2011 Sep; 30(9):764-8. PubMed ID: 21494172
[TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.
Choun K; Thai S; Pe R; Lorent N; Lynen L; van Griensven J
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):235-42. PubMed ID: 23324313
[TBL] [Abstract][Full Text] [Related]
37. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
Grulich AE
Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
[TBL] [Abstract][Full Text] [Related]
38. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
Elizabeth C
AIDS; 2021 Oct; 35(12):1973-1985. PubMed ID: 34049355
[TBL] [Abstract][Full Text] [Related]
39. Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: a population-based cohort study.
Lin CS; Lin C; Weng SF; Lin SW; Lin YS
Cancer Epidemiol; 2013 Oct; 37(5):719-24. PubMed ID: 23770024
[TBL] [Abstract][Full Text] [Related]
40. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.
Achenbach CJ; Cole SR; Kitahata MM; Casper C; Willig JH; Mugavero MJ; Saag MS
AIDS; 2011 Mar; 25(5):691-700. PubMed ID: 21160411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
